Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial by Priotto, Gerardo, Dr, Kasparian, Serena, MD, Mutombo, Wilfried, MD, Ngouama, Daniel, MD, Ghorashian, Sara, MD, Arnold, Ute, MD, Ghabri, Salah, PhD, Baudin, Elisabeth, MD, Buard, Vincent, MD, Kazadi-Kyanza, Serge, MD, Ilunga, Médard, MD, Mutangala, Willy, MD, Pohlig, Gabriele, PhD, Schmid, Caecilia, PhD, Karunakara, Unni, PhD, Torreele, Els, PhD, Kande, Victor, MD

Get full text

Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study by Kande Betu Ku Mesu, Victor, Mutombo Kalonji, Wilfried, Bardonneau, Clélia, Valverde Mordt, Olaf, Ngolo Tete, Digas, Blesson, Séverine, Simon, François, Delhomme, Sophie, Bernhard, Sonja, Mahenzi Mbembo, Hélène, Mpia Moke, Christian, Lumeya Vuvu, Steven, Mudji E'kitiak, Junior, Akwaso Masa, Felix, Mukendi Ilunga, Melchias, Mpoyi Muamba Nzambi, Dieudonné, Mayala Malu, Tim, Kapongo Tshilumbwa, Serge, Botalema Bolengi, Franck, Nkieri Matsho, Mathieu, Lumbala, Crispin, Scherrer, Bruno, Strub-Wourgaft, Nathalie, Tarral, Antoine

Get full text